These stocks are down at least 20% from 2021 highs, but Wall Street sees them gaining as much as 87% in 2022<blockquote>这些股票较2021年高点下跌至少20%,但华尔街预计2022年它们将上涨87%</blockquote>
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year<blockquote>生物技术领域未来一周(12月26日至1月1日):Xeris FDA决定,等待今年最后一周的临床数据成为焦点</blockquote>